1. Visus Therapeutics, a biopharmaceutical company for eye care, named Eric Donnenfeld, MD, to its board of directors.
2. Retina specialist Dr. Caroline Baumal was appointed chief medical officer of Apellis Pharmaceuticals.
3. EyePoint Pharmaceuticals tapped its COO, Jay Duker, MD, as its next president.
4. Iveric Bio, a biopharmaceutical company for retinal diseases, named Pravin Dugel, MD, to its board of directors.
5. Robert van der Vaart, MD, at N.C.-based Wilmington Eye performed the first successful implant of the iStent Infinite at Wilmington Eye Surgery Center. It marks the first time a glaucoma device was implanted in either of the Carolinas.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
